State of the art management of BPSD in dementia;Zeitgemäßes management von nicht kognitiven symptomen bei demenz

Psychiatrische Praxis

Volumn 32, Issue 1, 2005, Pages 31-38

  Rainer, Michael K ^a   Mucke, Hermann A M ^b   Masching, Andreas J ^a   Haushofer, Manfred ^a   Karger, Martin ^c   Kasper, Siegfried ^d   Kurz, Alexander ^e  

^a DANUBE HOSPITAL   (Austria)

^b H M Pharma Consultancy   (Austria)

^c Psychiatrische Klinik   (Germany)

^d UNIVERSITY OF VIENNA   (Austria)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; BUSPIRONE; CARBAMAZEPINE; CHLORAL HYDRATE; CITALOPRAM; CLOZAPINE; FLUOXETINE; HALOPERIDOL; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OLANZAPINE; OXAZEPAM; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE; ZOLPIDEM; PSYCHOTROPIC AGENT;

AGITATION; ANXIETY DISORDER; BEHAVIOR; DEMENTIA; DEPRESSION; DRUG INDICATION; GENERALIZED ANXIETY DISORDER; HUMAN; INSOMNIA; PARKINSON DISEASE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; REVIEW; SYMPTOMATOLOGY; ALZHEIMER DISEASE; ARTICLE; AUSTRIA; COMORBIDITY; CROSS-SECTIONAL STUDY; GERMANY; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; MENTAL DISEASE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SWITZERLAND;

ALZHEIMER DISEASE; ATTITUDE OF HEALTH PERSONNEL; AUSTRIA; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEMENTIA; GERMANY; HEALTH SURVEYS; HUMANS; MENTAL DISORDERS; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; SWITZERLAND;

EID: 12744253780     PISSN: 03034259     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-814885     Document Type: Review

References (44)

1. Allain H, Dautzenberg PH, Maurer K et al. Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patient with cognitive impairment, Psychopharmacology (Berl) 2000; 148: 361-366
2. Ancill RJ, Carlyle WW, Liang RA, Holliday SG. Agitation in the demented elderly: a role for benzodiazepines? Int Clin Psychopharmacology 1991; 6: 141-146
3. Ballard C, Neill D, O'Brien J, Mc Keith IG, Ince P, Perry R. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord 2000; 59: 97-106
4. Brodaty H, Ames D, Snowdon J et al. A randomized placebocontrolled trial of risperidone for the treatment of aggression, agitation and psychosis of dementia. J Clin Psychiatry 2003; 64 (2): 134-143
5. Cacchione PZ, Culpik I, Lang J, Tripp-Reimer T. Clinical profile of acute confusion in the long-term care setting. Clinical nursing research 2003; 12 (2): 145-158
6. Chesrow EJ, Kaplitz SE, Vetra H, Breme JT, Marquardt GH. Blind study of oxazepam in the management of geriatric patients with behavioral problems. Clinical Medicine 1965; 13: 1001-1005
7. Clark WS, Street JS, Feldman PD et al. The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease, J Clin Psychiatry 2000; 62: 34-40
8. Compton SA, Flanagan P, Gregg W. Elder abuse in people with dementia in Northern Ireland: Prevalence and predictors in cases referred to a psychiatry of old age service, Int J Geriatr Psychiatry 1997; 12: 632-635
9. Cooney C, Mortimer A, Elder abuse and dementia - a pilot study, Int J Soc Psychiatry 1995; 41: 276-283
10. Coyne AC, Reichman WE, Berbig LJ. The relationship between dementia and elder abuse. Am J Psychiatry 1993; 150: 643-646
11. Deyn PP De, Katz IR, Control of aggression and agitation in patients with dementia: efficacy and safety of risperidone. Int J Geriatr Psychiatry 2000; 15, Suppl 1:14-22
12. Deyn PP De, Rabheru K, Rasmussen A et al. A randomized trial of risperidone, placebo and haloperidol for behavioral symptoms of dementia. Neurology 1999; 53 (5): 946-955
13. Devanand DP, Jacobs DM, Tang MX. The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psych 1997; 54: 257-263
14. Dewey Jr RB, O'Suileabhain PE. Treatment of drug induced psychosis with quetiapine and clozapine in Parkinson's disease. Neurology 2000; 55: 1753-1754
15. Donaldson C, Tarrier N, Burns A. The impact of the symptoms of dementia on caregivers. British Journal of Psychiatry 1997; 170: 62-68
16. Ferretti L, Mc Curry SM, Logsdon R, Gibbons L, Teri L, Anxiety and Alzheimer's disease, J Geriatr Psychiatry Neurol 2001; 14: 52-58
17. Finkel S. Introduction to behavioural and psychological symptoms of dementia (BPSD), Int J Geriatr Psychiatry 2000; 15: S2-S4
18. Finkel S, Costa e Silva J, Cohen G, Miller S, Sartorius N. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment, Int Psychogeriatr 1996; 8: 497-500
19. Grafstrom M, Nordberg A, Winblad B, Abuse is in the eye of the beholder. Report by family members about abuse of demented persons in home care. A total population-based study, Scand J Soc Med 1993; 21: 247-255
20. Herrmann N, Recommendations for the management of behavioral and psychological symptoms of dementia. Can J Neurol Sci 2001; 28, Suppl 1: 96-107
21. Katz IR,JesseDV, Mintzer JE et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial: Risperidone Study Group. J Clin Psychiatry 1999; 60 (29): 107-115
22. Kirchner V, Kelly CA, Harvey RJ. Thioridazine for demential (Cochrane review). Oxford: Cochrane Library, 1999; 1. Update Software
23. Kurrle SE, Sadler PM, Cameron ID. Patterns of elder abuse. Med J Aust 1992; 157: 673-676
24. Lanctot KL, Best TS, Mittmann N. Efficacy and safety of neuroleptics in behavioral disorders associated with dementia. Journal of Clinical Psychiatry 1998; 59: 550-561
25. Leger JM, Moulias R, Vellas B, Monfort JC, Chapuy P, Robert P, Knellesen S, Gerard D. Causes and consequences of elderly's agitated and aggressive behavior. Encephale 2000; 26: 32-43
26. Manepalli J, Grossberg GT, Mueller C. Prevalence of delirium and urinary tract infection in a psychogeriatric unit. J Geriatr Psychiatry Neurol 1990; 3: 198-202
27. Mc Shane R, Keene J, Gedling K, Fairburn C, Jacoby R, Hope T. Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow-up. British Medical Journal 1997; 314: 266-270
28. Müller-Thomsen T, Meins W, Manecke S. Psychiatrische Störungen im Alter und deren psychosoziale Hintergründe. Psychiat Prax 1999; 26: 267-272
29. Olanow CW, Watts RL, Koller WC. Analgorithm (decision tree) for the management of Parkinsons disease. Treatment guidelines. Neurology 2001; 56 (suppl): 51-88
30. Qizilbash N, Schneider LS, Chui H, Tariot P, Brodaty H, Kaye J, Erkinjuntti T. Evidence-based Dementia. Practice, 2002: 678-681
31. Rainer M, Mucke HAM, Masching A, Haushofer M. Nichtkognitive Symptomprofile bei Demenzpatienten, Psychiat Prax 1999; 26: 71-75
32. Rainer M, Jungwirth S, Krüger-Rainer C, Croy A, Gatterer G, Haushofer M, Pflegende Angehörige von Demenzerkrankten: Belastungsfaktoren und deren Auswirkung. Psychiat Prax 2002; 29: 142-147
33. Rainer MK, Masching AJ, Ertl MG, Kraxberger E, Haushofer M. Effect of Risperidon on Behavioral and Psychological Symptoms and Cognitive Function in Dementia. J Clin Psychiatry 2001; 62: 894-900
34. Rainer MK, Mucke HAM, Krüger-Rainer C, Haushofer M, Kasper S. Zotepine for Behavioral and Psychological Symptoms in Dementia, CNS Drugs 2004; 18(1): 49-55
35. Riedel-Heller SG, Stelzner G, Schork A, Angermeyer MC. Gerontopsychiatrische Kompetenz ist gefragt. Psychiat Prax 1999; 26: 273-276
36. Schneider LS, Pollock VE, Lyness SA. A meta-analysis of controlled trials of neuroleptics treatment in dementia. Journal of the American Geriatric Soc 1990; 38: 553-563
37. Schulze Mönking H, Hornung WP. Prävalenz und Behandlung von depressiven Syndromen in Altenheimen. Psychiat Prax 1998; 25: 183-185
38. Sloan R. Use of Atypical Antipsychotic Drugs in patients with Dementia. American Physicans 2003; 67: 2335-2340
39. Stoppe G, Staedt J. Psychopharmakotherapie von Verhaltensstörungen bei Demenzkranken. Zeitschrift für Gerontologie und Geriatrie 1999; 32, 3: 153-158
40. Stoppe G, Koller M, Hornig C, Lund I, Sandholzer H, Staedt J. Gerontopsychiatrische Behandlung im Vergleich zwischen integrierter Versorgung an einer Universität und separierter Versorgung an einem Landeskrankenhaus. Psychiat Prax 1999; 26: 277-282
41. Tariot PN, Ismail MS. Use of quetiapine in elderly patients. J Clin Psychiatry 2002; 63, Suppl 13: 21-26
42. Teri L, Ferretti LE, Gibbons LE, Logsdon RG, McCurry SM, Kukull WA, McCormick WC, Bowen JD, Larson EB. Anxiety of Alzheimer's disease: prevalence, and comorbidity. J Gerontol A Biol Sci Med Sci 1999; 54: M348-M352
43. Walker Z, Grace J, Overshot R et al. Olanzapine in dementia with Lewy bodies: a clinical study. Int J Geriatr Psychiatry 1999; 14: 459-466
44. Zeeh J, Poltz S. Exsikkose bei geriatrischen Patienten, Flüssigkeit substituieren - das geht auch subkutan! MMW-Fortschr Med 2000; 142: 40-42